About Us

Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.

Press Releases

Aug 9, 2023

Registration Now Open for 2024 MDA Clinical & Scientific Conference, to Showcase Cutting Edge Research Advancements and Clinical Achievements in Neuromuscular Disease

Global leaders will gather at the annual MDA Clinical & Scientific Conference March 3-6, 2024. Presentations will be held in-person in Orlando, Florida and available virtually.
Jul 11, 2023

Introducing Muscular Dystrophy Association's New Quest Media Seasonal Product Guide, Developed with Endorsements by MDA Ambassadors

Five MDA Ambassadors from across the country recommend over 30 products in the MDA Quest Media Summer Product Guide for people living with disabilities.
Jun 27, 2023

Muscular Dystrophy Association Celebrates FDA Approval of UCB’s RYSTIGGO for the Treatment of Generalized Myasthenia Gravis
Jun 22, 2023

Muscular Dystrophy Association Celebrates FDA Approval of Sarepta Therapeutics' ELEVIDYS for Treatment of Duchenne Muscular Dystrophy
Jun 20, 2023

Muscular Dystrophy Association Celebrates FDA Approval of argenx's Vyvgart Hytrulo Injection for Treatment of Generalized Myasthenia Gravis
Jun 15, 2023

CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy

« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »

Find MDA
in your Community